A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease

por Moss, Donald E, Fariello, Ruggero G, Sahlmann, Jörg, Sumaya, Isabel, Pericle, Federica, Braglia, Enrico
Publicado 2013